CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer

NCT00932724 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
77
Enrollment
INDUSTRY
Sponsor class

Stopped The sponsor declared the early termination of the study due to poor recruitment of patients.

Conditions

Interventions

Sponsor

Cytavis Biopharma GmbH

Collaborators